These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 7942149

  • 1. Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum.
    Rogers MJ, Watts DJ, Russell RG, Ji X, Xiong X, Blackburn GM, Bayless AV, Ebetino FH.
    J Bone Miner Res; 1994 Jul; 9(7):1029-39. PubMed ID: 7942149
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationships of new heterocycle-containing bisphosphonates as inhibitors of bone resorption and as inhibitors of growth of Dictyostelium discoideum amoebae.
    Rogers MJ, Xiong X, Brown RJ, Watts DJ, Russell RG, Bayless AV, Ebetino FH.
    Mol Pharmacol; 1995 Feb; 47(2):398-402. PubMed ID: 7870050
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum.
    Brown RJ, van Beek E, Watts DJ, Löwik CW, Papapoulos SE.
    J Bone Miner Res; 1998 Feb; 13(2):253-8. PubMed ID: 9495518
    [Abstract] [Full Text] [Related]

  • 4. Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum.
    Rogers MJ, Ji X, Russell RG, Blackburn GM, Williamson MP, Bayless AV, Ebetino FH, Watts DJ.
    Biochem J; 1994 Oct 01; 303 ( Pt 1)(Pt 1):303-11. PubMed ID: 7945256
    [Abstract] [Full Text] [Related]

  • 5. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
    Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ.
    J Pharmacol Exp Ther; 2001 Feb 01; 296(2):235-42. PubMed ID: 11160603
    [Abstract] [Full Text] [Related]

  • 6. From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates.
    Rogers MJ.
    Calcif Tissue Int; 2004 Dec 01; 75(6):451-61. PubMed ID: 15332174
    [Abstract] [Full Text] [Related]

  • 7. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
    David P, Nguyen H, Barbier A, Baron R.
    J Bone Miner Res; 1996 Oct 01; 11(10):1498-507. PubMed ID: 8889850
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of growth of Dictyostelium discoideum amoebae by bisphosphonate drugs is dependent on cellular uptake.
    Rogers MJ, Xiong X, Ji X, Mönkkönen J, Russell RG, Williamson MP, Ebetino FH, Watts DJ.
    Pharm Res; 1997 May 01; 14(5):625-30. PubMed ID: 9165534
    [Abstract] [Full Text] [Related]

  • 9. The relationship between the chemistry and biological activity of the bisphosphonates.
    Ebetino FH, Hogan AM, Sun S, Tsoumpra MK, Duan X, Triffitt JT, Kwaasi AA, Dunford JE, Barnett BL, Oppermann U, Lundy MW, Boyde A, Kashemirov BA, McKenna CE, Russell RG.
    Bone; 2011 Jul 01; 49(1):20-33. PubMed ID: 21497677
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonates: mode of action and pharmacology.
    Russell RG.
    Pediatrics; 2007 Mar 01; 119 Suppl 2():S150-62. PubMed ID: 17332236
    [Abstract] [Full Text] [Related]

  • 11. Bisphosphonates: structure-activity relations from a clinical perspective.
    Papapoulos SE.
    Medicina (B Aires); 1997 Mar 01; 57 Suppl 1():61-4. PubMed ID: 9567357
    [Abstract] [Full Text] [Related]

  • 12. Molecular mechanisms of action of bisphosphonates: current status.
    Roelofs AJ, Thompson K, Gordon S, Rogers MJ.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 2):6222s-6230s. PubMed ID: 17062705
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of action of the bisphosphonates.
    Fleisch H.
    Medicina (B Aires); 1997 Oct 15; 57 Suppl 1():65-75. PubMed ID: 9567358
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes.
    Rogers MJ, Brown RJ, Hodkin V, Blackburn GM, Russell RG, Watts DJ.
    Biochem Biophys Res Commun; 1996 Jul 25; 224(3):863-9. PubMed ID: 8713136
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of halogenated bisphosphonates by the cellular slime mould Dictyostelium discoideum.
    Rogers MJ, Russell RG, Blackburn GM, Williamson MP, Watts DJ.
    Biochem Biophys Res Commun; 1992 Nov 30; 189(1):414-23. PubMed ID: 1333194
    [Abstract] [Full Text] [Related]

  • 16. Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.
    Sanders JM, Song Y, Chan JM, Zhang Y, Jennings S, Kosztowski T, Odeh S, Flessner R, Schwerdtfeger C, Kotsikorou E, Meints GA, Gómez AO, González-Pacanowska D, Raker AM, Wang H, van Beek ER, Papapoulos SE, Morita CT, Oldfield E.
    J Med Chem; 2005 Apr 21; 48(8):2957-63. PubMed ID: 15828834
    [Abstract] [Full Text] [Related]

  • 17. Nitrogen-containing bisphosphonate mechanism of action.
    Reszka AA, Rodan GA.
    Mini Rev Med Chem; 2004 Sep 21; 4(7):711-9. PubMed ID: 15379639
    [Abstract] [Full Text] [Related]

  • 18. [Mechanisms of action in bisphosphonates].
    Hoshino H, Yamazaki K.
    Clin Calcium; 2005 Jul 21; 15(7):88-92. PubMed ID: 15995302
    [Abstract] [Full Text] [Related]

  • 19. The cellular mechanism of action of bisphosphonates.
    Hughes DE, Mian M, Guilland-Cumming DF, Russell RG.
    Drugs Exp Clin Res; 1991 Jul 21; 17(2):109-14. PubMed ID: 1864224
    [Abstract] [Full Text] [Related]

  • 20. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
    Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH.
    Ann N Y Acad Sci; 2007 Nov 21; 1117():209-57. PubMed ID: 18056045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.